| Harvey A Brown, MD | |
|
25825 Vermont Ave, Harbor City, CA 90710-3518 | |
| (310) 325-5111 | |
| Not Available |
| Full Name | Harvey A Brown |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 25825 Vermont Ave, Harbor City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952459760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | G26910 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harvey A Brown, MD 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 | Harvey A Brown, MD 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 |
News Archive
Ventas, Inc. today announced that Moody's Investors Service has raised the rating on the Company's senior unsecured debt to Baa3 from Ba1, with a stable outlook. This action by Moody's follows similar ratings upgrades from Fitch Ratings in July 2009 (unsecured debt raised to BBB from BBB-, with a stable outlook) and Standard & Poor's Ratings Services in February 2008 (unsecured debt raised to BBB- from BB+, with a stable outlook). The Company's senior unsecured debt now carries an investment grade rating from all three major ratings agencies.
Researchers at the Moffitt Cancer Center have discovered a control mechanism that can trigger the development of myelodysplastic syndromes (MDS), a group of blood cancers. This finding may lead to therapies capable of preventing the progression of these diseases.
Children's Hospital Boston, with the Broad Institute and Harvard Medical School, has been awarded a Grand Opportunity grant from the National Institute of Mental Health as part of the federal stimulus package, to pursue "whole-genome" sequencing of patients with autism, using new technologies for rapid DNA sequencing to better understand autism's causes.
The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products. This new shared system will replace the individual REMS and allow prescribers and pharmacies to enroll into just one system, easing the burden on the health care system.
› Verified 1 days ago
Kenneth A. Feldman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Jasmine Simone Hayes-adams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Teddy Y. Tong, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Mamdouh L. Nakla, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Alexander H. Tu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
John C. Terrell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Nader Ameli, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 |